Increased intestinal permeability in rats with graft versus host disease

Gut

Volumn 39, Issue 2, 1996, Pages 291-298

  Koltun, W A ^a,b   Bloomer, M M ^a   Colony, P ^a   Kauffman, G L ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclosporine A; Graft versus host disease; Intestinal permeability; Small bowel transplantation

Indexed keywords

CYCLOSPORIN A; LACTULOSE; RHAMNOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HISTOLOGY; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; INTESTINE TRANSPLANTATION; LYMPHOCYTE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNIQUE;

EID: 0029793736     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.2.291     Document Type: Article

References (38)

1. Brubaker DB. Immunopathogenic mechanisms of post-transfusion graft-vs-host disease. Proc Soc Exp Biol Med 1993; 202: 122-47.
2. Grant D, Garcia B, Wall W, Oheme-Fianko D, Zhong R, Mimeault R, et al. Graft-versus-host disease after clinical small bowel/liver transplantation. Transplant Proc 1990; 22: 2464.
3. Cohen Z, Silverman RE, Wassef R, Levy GA, Burnstein M, Cullen J, et al. Small intestinal transplantation using cyclosporine. Transplantation 1986; 42: 613-21.
4. Wick MR, Moore SB, Gastinear DA, Hoagland HC. Immunologic, clinical and pathologic aspects of human graft-versus-host disease. Mayo Clin Proc 1983; 58: 603-12.
5. Pirenne J. Study on mechanisms of graft-versus-host disease following small bowel transplantation. Acta Gastroenterol Belg 1992; LV: 17-22.
6. Sanderson IR, Boulton P, Menzies I, Walker-Smith JA. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut 1987; 28: 1073-6.
7. Pearson ADJ, Eastham EJ, Laker MF, Craft AW, Nelson R. Intestinal permeability in children with Crohn's disease and coeliac disease. BMJ 1982; 285: 20-1.
8. Bjarnason I. Intestinal permeability. Gut 1994; 35 (Suppl 1): S18-22.
9. Selby P, McElwain TJ, Crofts M, Lopes N, Mundy J. 51-CrEDTA test for intestinal permeability. Lancet 1984; ii: 38-9.
10. Mahendra P, Bedlow AJ, Ager S, Ancliff PJ, Wraight EP, Marcus RE. Technetium(99mTc)-labelled white cell scanning, 51 CR-EDTA and 14C-mannitol-labelled intestinal permeability studies: non-invasive methods of diagnosing acute intestinal graft-versus-host disease. Bone Marrow Transplant 1994; 13: 835-7.
11. Grant D, Hurlbut D, Zhong R, Wang P, Chen H, Garcia B, et al. Intestinal permeability and bacterial translocation following small bowel transplantation in the rat. Transplantation 1991; 52: 221-4.
12. Sigalet DL, Kneteman NM, Fedorak RN, Kizilisik AT, Thomson AB. Intestinal function following allogenic small intestinal transplantation in the rat. Transplantation 1992; 53: 264-71.
13. Koltun WA, Diamantstein T, Kirkman RL. Synergism between anti-interleukin-2 receptor monoclonal antibody and cyclosporine in small bowel transplantation. Curr Surg 1987; 44: 315-8.
14. Pirenne J, Degiovanni G, Franchimont N, Scheppens G, Meager T, Dunn DL. Graft vs host disease after small bowel transplantation or lymphocyte transfer is associated with tumor necrosis factor alpha in the serum. Surg Forum 1990; 49: 389-91.
15. Hamilton I, Rothwell J, Archer D, Axon TR. Permeability of the rat small intestine to carbohydrate probe molecules. Clin Sci 1987; 73: 189-96.
16. Fleming SC, Kapembwa MS, Laker MF, Levin GF, Griffin GE. Rapid and simultaneous determination of lactulose and mannitol in urine, by HPLC with pulsed amperometric detection, for use in studies of intestinal permeability. Clin Chem 1990; 36: 797-9.
17. Rocklin RD, Pohl CA. Determination of carbohydrates by anion exchange chromatography with pulsed amperometric detection. Journal of Liquid Chromatography 1983; 6: 1577-90.
18. Mowat AM. Antibodies to IFN-γ prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology 1989; 68: 18-23.
19. MacDonald TT, Ferguson A. Hypersensitivity reactions in the small intestine. The effects of allograft rejection and of graft-versus-host disease of epithelial cell kinetics. Cell Tissue Kinet 1977; 10: 301-12.
20. Mowat AM, Ferguson A. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine. Gastroeterology 1982; 83: 417-23.
21. Ohri SK, Somasundaram S, Koak Y, Macpherson A, Keogh BH, Taylor KM, et al. The effect of intestinal hypoperfusion during cardiopulmonary bypass surgery on saccharide permeation and intestinal permeability in man. Gastroenterology 1994; 106: 318-23.
22. Roumen RM, van der Vliet JA, Wevers RA, Goris RJ. Intestinal permeability is increased after major vascular surgery. J Vasc Surg 1993; 17: 734-7.
23. Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990; 125: 403-4.
24. Lampert IA, Moore RH, Huby R, Cohen J. Observations on the role of endotoxin in graft-versus-host disease. In: Levin J, ed. Bacterial endotoxins: pathophysiological effects, clinical significance, and pharmacological control. New York: Alan R Liss, 1988: 351-9.
25. Faulkner L, Rapson N, Moore R, Cohen J. The influence of the gut flora on graft versus host disease (GVHD) following allogeneic bone marrow transplantation experimental observations and possible mechanisms. In: Levin J, ed. Bacterial endotoxins: pathophysiological effects, clinical significance, and pharmacological control. New York: Alan R Liss, 1988: 195-206.
26. Van Bekkum DW, Knaan S. Brief communication. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. Natl Cancer Inst Monogr 1977; 58: 787-9.
27. Keast D, Walters MNI. The pathology of murine runting and its modification by neomycin sulphate gavages. Immunology 1068; 15: 247-62.
28. Schmeiser T, Kurrle H, Arnold R, Heit W, Krieger D, Kubanek B, et al. The influence of the microbial flora on incidence of graft versus host disease in human allogeneic bone marrow transplantation. In: Wostmann BS, Pleasants JR, eds. Germfree research: microflora control and its application to the biomedical sciences. New York: Alan R Liss, 1985: 433-5.
29. Alexander JW, Boyce ST, Babcock GF, Gianotti L, Peck MD, Dunn DI., et al. The process of microbial translocation. Ann Surg 1990; 212: 496-512.
30. Elson CO, Reilly RW, Rosenberg IH. Small intestinal injury in the graft versus host reaction: an innocent bystander phenomenon. Gastroenterology 1977; 72: 886-9.
31. Piguet PF, Grau GE, Allet B, Vassalli P. Tumor necrosis factor/eachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med 1987; 166: 1280-9.
32. Adams RB, Planchon SM, Roche JK. IFN-γ modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 1993; 150: 2356-63.
33. Madara JL, Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 1989; 83: 724-7.
34. Hedberg CA, Reiser S, Reilly RW. Intestinal phase of the runting syndrome in mice. Transplantation 1968; 6: 104-10.
35. Elia M, Goren A, Behrens R, Barber RW, Neale G. Effect of total starvation and very low calorie diets on intestinal permeability in man. Clin Sci 1987; 73: 205-10.
36. Rhodes RS, Karnovsky MJ. Loss of macromolecular barrier function associated with surgical trauma to the intestine. Lab Invest 1971; 25: 220-9.
37. Penn RL, Maca RD, Berg RD. Increased translocation of bacteria from the gastrointestinal tracts of tumor-bearing mice Infect Immun 1985; 47: 793-8.
38. Chin W, Hay JB. A comparison of lymphocyte migration through intestinal lymph nodes, subcutaneous lymph nodes, and chronic inflammatory sites of sheep. Gastroenterology 1980; 79: 1231-42.